Benefits of Zebrafish Xenograft Models in Cancer Research

被引:43
作者
Chen, Xingyu [1 ,2 ]
Li, Yongyun [1 ,2 ]
Yao, Tengteng [1 ,2 ]
Jia, Renbing [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Ophthalmol, Shanghai, Peoples R China
[2] Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金
中国国家自然科学基金;
关键词
zebrafish model; tumor visualization; pharmacokinetics; tumor microenvironment; tumor model; IN-VIVO;
D O I
10.3389/fcell.2021.616551
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
As a promising in vivo tool for cancer research, zebrafish have been widely applied in various tumor studies. The zebrafish xenograft model is a low-cost, high-throughput tool for cancer research that can be established quickly and requires only a small sample size, which makes it favorite among researchers. Zebrafish patient-derived xenograft (zPDX) models provide promising evidence for short-term clinical treatment. In this review, we discuss the characteristics and advantages of zebrafish, such as their transparent and translucent features, the use of vascular fluorescence imaging, the establishment of metastatic and intracranial orthotopic models, individual pharmacokinetics measurements, and tumor microenvironment. Furthermore, we introduce how these characteristics and advantages are applied other in tumor studies. Finally, we discuss the future direction of the use of zebrafish in tumor studies and provide new ideas for the application of it.
引用
收藏
页数:14
相关论文
共 208 条
  • [1] Structure and function of the blood-brain barrier
    Abbott, N. Joan
    Patabendige, Adjanie A. K.
    Dolman, Diana E. M.
    Yusof, Siti R.
    Begley, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (01) : 13 - 25
  • [2] INTERFERENCE MICROSCOPE STUDIES OF CELL CONTACTS IN TISSUE CULTURE
    ABERCROMBIE, M
    AMBROSE, EJ
    [J]. EXPERIMENTAL CELL RESEARCH, 1958, 15 (02) : 332 - 345
  • [3] Ago Tetsuro, 2014, Fukuoka Acta Medica, V105, P125
  • [4] An inducible krasV12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening
    Anh Tuan Nguyen
    Emelyanov, Alexander
    Koh, Chor Hui Vivien
    Spitsbergen, Jan M.
    Parinov, Serguei
    Gong, Zhiyuan
    [J]. DISEASE MODELS & MECHANISMS, 2012, 5 (01) : 63 - 72
  • [5] Zebrafish In Vivo Models of Cancer and Metastasis
    Astell, Katy R.
    Sieger, Dirk
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (08): : 1 - 17
  • [6] What is a pericyte?
    Attwell, David
    Mishra, Anusha
    Hall, Catherine N.
    O'Farrell, Fergus M.
    Dalkara, Turgay
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (02) : 451 - 455
  • [7] Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines
    Avci, M. Ender
    Keskus, Ayse Gokce
    Targen, Seniye
    Isilak, M. Efe
    Ozturk, Mehmet
    Atalay, Rengul Cetin
    Adams, Michelle M.
    Konu, Ozlen
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [8] Physical confinement alters tumor cell adhesion and migration phenotypes
    Balzer, Eric M.
    Tong, Ziqiu
    Paul, Colin D.
    Hung, Wei-Chien
    Stroka, Kimberly M.
    Boggs, Amanda E.
    Martin, Stuart S.
    Konstantopoulos, Konstantinos
    [J]. FASEB JOURNAL, 2012, 26 (10) : 4045 - 4056
  • [9] PRMT5 as a druggable target for glioblastoma therapy
    Banasavadi-Siddegowda, Yeshavanth Kumar
    Welker, Alessandra M.
    An, Min
    Yang, Xiaozhi
    Zhou, Wei
    Shi, Guqin
    Imitola, Jaime
    Li, Chenglong
    Hsu, Sigmund
    Wang, Jiang
    Phelps, Mitch
    Zhang, Jianying
    Beattie, Christine E.
    Baiocchi, Robert
    Kaur, Balveen
    [J]. NEURO-ONCOLOGY, 2018, 20 (06) : 753 - 763
  • [10] Characteristics of compounds that cross the blood-brain barrier
    Banks, William A.
    [J]. BMC NEUROLOGY, 2009, 9